Recro Pharma to Report Fourth Quarter and Year End 2018 Financial Results

Conference Call
Conference Call and Webcast Scheduled for Tuesday, February 19, 2019 at 8:00 a.m. ET

MALVERN, PA — Recro Pharma, Inc. (NASDAQREPH), a revenue-generating specialty pharmaceutical company focused on therapeutics for the hospital and other acute care settings, announced that it will report fourth quarter and year-end financial results on Tuesday, February 19, 2019.

Recro’s management team will host a conference call and audio webcast at 8:00 a.m. ET on Tuesday, February 19, 2019, to discuss the financial results and recent operational highlights.

To access the conference call, please dial (844) 243-4691 (local) or (225) 283-0379 (international) at least 10 minutes prior to the start time and refer to conference ID 4094366.

A live audio webcast of the call will be available under “Events” in the Investor section of the Company’s website, https://ir.recropharma.com/events.

An archived webcast will be available on the Company’s website approximately two hours after the event and will be available for 30 days.

READ:  Neuronetics Receives FDA Clearance for Three-Minute TouchStar™ Treatment Protocol

Source: Recro Pharma, Inc., 490 Lapp Road, Malvern PA 19355

Thanks for visiting! MyChesCo brings reliable information and resources to Chester County, Pennsylvania. Please consider supporting us in our efforts. Your generous donation will help us continue this work and keep it free of charge. Show your support today by clicking here and becoming a patron.

Buy Us a Cup of Coffee